Inter Pharma Public Company Limited

SET:IP Stock Report

Market Cap: ฿1.8b

Inter Pharma Past Earnings Performance

Past criteria checks 2/6

Inter Pharma has been growing earnings at an average annual rate of 2.9%, while the Personal Products industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 34.6% per year. Inter Pharma's return on equity is 0.7%, and it has net margins of 0.6%.

Key information

2.9%

Earnings growth rate

-4.1%

EPS growth rate

Personal Products Industry Growth3.7%
Revenue growth rate34.6%
Return on equity0.7%
Net Margin0.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Inter Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SET:IP Revenue, expenses and earnings (THB Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,807116230
30 Jun 241,809206070
31 Mar 241,809275970
31 Dec 231,799515680
30 Sep 231,815915560
30 Jun 231,7751085400
31 Mar 231,7391285130
31 Dec 221,5341194580
30 Sep 221,3851303900
30 Jun 221,2261253390
31 Mar 221,0161182840
31 Dec 219211052670
30 Sep 21760682530
30 Jun 21626632300
31 Mar 21526562020
31 Dec 20447531870
30 Sep 20408621620
30 Jun 20390571550
31 Mar 20389561560
31 Dec 19376431570
30 Sep 19371281750
30 Jun 19365271760
31 Mar 19343241690
31 Dec 18318301520
31 Dec 17248161200
31 Dec 1612516590

Quality Earnings: IP has high quality earnings.

Growing Profit Margin: IP's current net profit margins (0.6%) are lower than last year (5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: IP's earnings have grown by 2.9% per year over the past 5 years.

Accelerating Growth: IP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: IP had negative earnings growth (-87.4%) over the past year, making it difficult to compare to the Personal Products industry average (-3.6%).

Return on Equity

High ROE: IP's Return on Equity (0.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 04:34
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Inter Pharma Public Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution